Detailed Agenda 2019

Please click on arrow (left of each item) to display activities for the day

  • + -

    Thursday, October 31, 2019

    9:00 AM- 12:00 AM

    Special Pre-Summit Session: How to Adapt to the Changing Environment in CNS Pediatric Clinical Development
    Eva Kohegyi, MD, Sr. Director, Global Clinical Development, Otsuka
    Sarah D. Atkinson MD, Director & Principal Investigator, Finger Lakes Clinical Research
    Philippe Auby MD, CEO & President, Otsuka Europe
    Michelle Bailey MD, Senior Medical Director, Syneos Health
    Joan Busner, Ph.D., Clinical Vice President, Signant Health
    Ann Childress MD, President, Center for Psychiatry and Behavioral Medicine
    Kevin Cox MD, Project Physician, Otsuka
    Andrew Moniz, Vice President Clinical Development CNS, Syneos Health
    Mark Opler Ph.D, Chief Research Officer, MedAvante-ProPhase
    Amee Patel Ph.D, Clinical Scientist, Clinical Surveillance and Training, Syneos Health
    Robert Riesenberg MD, Founder and Principal Investigator, Atlanta Center for Medical Research
    Elias Sarkis MD, Founder and Principal Investigator, Sarkis Family Psychiatry

    12:00 PM- 1:30 PM

    Lunch
    -- On Own --

    1:30 PM- 3:00 PM

    CNS Summit 2019 Leadership Council Meeting
    -- Members of Leadership Council Only --

    3:30 PM- 4:30 PM

    SPECIAL RECEPTION
    -- By Invitation Only --

    4:30 PM- 5:00 PM

    CNS Summit 2019 New Participant Reception

    5:00 pm- 6:30 pm

    CNS Summit 2019 Welcome Reception
    -- Everyone Welcome! --
  • + -

    Friday, November 1, 2019

    7:00 AM- 7:45 AM

    Breakfast

    8:00 AM- 12:30 PM

    Opening Session

    CNS Summit 2019 Keynote Session

    Ali Parsa, CEO, Babylon Health
    Junaid Bajwa, Digital Centre of Excellence, Merck
    Amy Abernethy, Principal Deputy Commissioner, FDA
    Amir Kalali, Chief Curator, CNS Summit
    George Goldsmith, CEO & Co-Founder, Compass Pathways
    Ekaterina Malievskaia, Chief Innovation Officer & Co-Founder, Compass Pathways
    Jane Metcalfe, Founder, Neo.Life
    Bakul Patel, Director, Division of Digital Health, FDA
    Asif Dhar, Chief Health Informatics Officer & Principal, Deloitte Consulting
    Jamie Macdonald, CEO, Parexel
    Greg Hersch, Head, VP Innovation Global Development Operations, Novartis
    Benjamine Liu, CEO & Co-Founder, Trialspark
    Dina Katabi, Professor, MIT

    CNS Summit 2019 10th Anniversary Special Session

    12:30 pm- 1:00 pm

    Lunch (provided)

    1:00 pm- 3:00 pm

    CNS Summit Spotlight Sessions:

    Spotlight: Artificial Intelligence     1-2pm
              Milind Kamkolkar, Chief Data Officer, Cellarity
              Najat Khan, Global Head, R&D Strategy and Operations, Janssen
              Jane Tiller, Chief Medical Officer, BlackThorn Therapeutics
              Naveen Rao, GM, Artificial Intelligence Products Group, Intel
              Dina Katabi, Professor, MIT
              Chair: Iya Khalil, Co-Founder, GNS Healthcare

    Spotlight: Artificial Intelligence     2-3pm
              Adam Hanina, CEO, AiCure
              Tim Peters-Strickland, VP, Otsuka
              Cynthia Verst, President, Clinical Operations R&D, IQVIA
              Co-Chair: Matt Pipke, Chief Technology Officer, PhysIQ
              Co-Chair: Arnaub Chatterjee, SVP, Acorn AI, Medidata
              Co-Chair: Junaid Bajwa, Global Lead, Strategic Alliances, Digital Centre of Excellence, Merck

    Spotlight: Digital Therapeutics     1-2pm
              Corey McCann, CEO, Pear Therapeutics
              Eddie Martucci, CEO, Akili
              Brent Vaughan, CEO, Cognoa
              James Boiani, Partner, Life Sciences, Epstein Becker & Green P.C.
              Chair: Ed Cox, CEO, Dthera

    Spotlight: Neuroscience       1-3pm
              Harry Tracy, President, NI Research
              Sharon Mates, CEO, Intra-Cellular Therapies
              Bill Martin, CEO, BlackThorn Therapeutics
              Michael Gold, VP, Development Neurosciences, AbbVie
              Kenneth Koblan, Chief Scientific Officer, Sunovion
              Al Robichaud, Chief Scientific Officer, Sage Therapeutics
              Co-Chair: Atul Mahableshwarkar, Sr Vice President, Research & Development, Emalex Biosciences
              Co-Chair: Roger Bullock, Chief Medical Officer, Oryzon Genomics

    Spotlight: Real World Evidence: The Promise vs. The Reality       2-3pm
              Luca Pani, VP, Regulatory & Market Access Strategies, VeraSci
              Linus Jonsson, VP Medical Outcomes, Research, Lundbeck
              Vijay Barathan, Optum Ventures
              Co-Chair: Joydeep Sarkar, Chief Analytics Officer, Holmusk
              Co-Chair: Jeremy Wyatt, President, ActiGraph

    Spotlight: Putting Innovation into Practice: Barriers, Enablers and Solutions       2-3pm
              Craig Lipset, Founder & Advisor, Clinical Innovation Partners
              Greg Hersch, Novartis
              Lisa La Luna, SVP of Patient Advocacy, SME & Senior Advisor, WCG Clinical
              Chair: Sy Pretorius, EVP, Chief Medical & Scientific Officer, Parexel

    Spotlight: Behavioral Science + Human-Centered Design: Better Clinical Research by Partnering with Patients       1-2pm
              Kathleen Starr, Managing Director, Behavioral Science, Syneos Health
              Jodi Scarbrough, Director, Custom Research, Syneos Health
              Luke Kramer, Executive Director, The STARR Coalition
              Chair: Alexandria Wise-Rankovic, SVP CNS Clinical Development, Syneos Health

    Innovation Showcase Updates       1-3pm
              Nick Bott, Chief Science Officer, Neurotrack Technologies
              Chris Berka, CEO, Advanced Brain Monitoring
              Ellen Frank, Co Founder & CEO, HealthRhythms
              Hugo Geerts, Chief Scientific Officer, In Silico Biosciences
              Thomas Shiovitz, President, CTSdatabase
              Andy Coravos, Co Founder & CEO, Elektra Labs 
              Matteo Lai, Co-founder & CEO, Empatica
              Chris Wasden, Head of DTx, Happify
              Eric Gordon, Founder & CEO, Atentiv
              Chair: Spyros Papapetropoulos, Dept of Neurology, MGH

    New Solutions Presentations       1-3pm
              Simon Collinson, Chief Science Officer, Savonix
              Paul Donnelly, Director, BD & Strategic Alliances, Data Cubed
              Gary Zammit, President & CEO, Clinilabs Drug Developement Corp
              Andrew Schachter, Founder & CEO, Axiom Real-Time Metrics
              Murray Rosenthal, Medical Advisory Board, Oska Wellness
              Michael Murphy, Chief Medical & Scientific Officer, Worldwide Clinical Trials
              Sherilyn Adcock, EVP Medical & Scientific Affairs Early Development, Worldwide Clinical Trials
              Chair: Stephanie Pfister, Head of Clinical Operations Late Phase, Cerevel Therapeutics

    3:30 pm- 5:00 pm

    One-to-One Networking Sessions

    5:00 pm- 7:00 pm

    Evening Reception, Posters & Exhibits
  • + -

    Saturday, November 2, 2019

    7:00 AM- 7:45 AM

    Breakfast

    Alternative Breakfast: Diversity in Leadership Meeting (Open to all participants)

    8:00 AM - 11:45 PM

    Opening Session

    CNS Summit 2019 Keynote Session
    Jessica Mega, Chief Medical & Scientific Officer, Verily
    Reed Tuckson, Managing Director, Tuckson Health Connections
    Amir Kalali, Chief Curator, CNS Summit
    Mona Siddiqui, Chief Data Officer, Dept. of Health and Human Services (HHS)
    Naveen Rao, GM, Artificial Intelligence Products Group, Intel
    Antony Loebel, President & CEO, Sunovion
    Rob Scott, Chief Medical Officer, Abbvie
    Glen de Vries, President, Medidata
    Gil Bashe, Managing Partner, Global Health, Finn Partners
    Pravin Jadhav, Sr. Director, Innovation and Business Transformation, Corporate Projects, Otsuka Pharmaceuticals
    Robert Hariri, Founder, Chairman & CEO, Celularity Inc.
    Spyros Papapetropoulos, Dept of Neurology, MGH
    Deborah Scher, Executive Advisor to the Secretary, US Department of Veterans Affairs
    Jennifer Goldsack, Interim Executive Director, Digital Medicine Society (DiMe)
    Andy Coravos, Co-founder & CEO, Elektra Labs

    Crystal Ball Session:
              Don Jones, CDO, Scripps
              Glen de Vries, President, Medidata
              Michelle Longmire, CEO, Medable
              Mike Rea, CEO, IDEA Pharma
              Steve Rosenberg, SVP and GM, Oracle Health Sciences
              Cynthia Verst, President, R&DS Design & Delivery Innovation, IQVIA
              Taren Grom, Editor-in-Chief, PharmaVoice
              Rob Wright, Editor-in-Chief, Life Science Leaders
              Jamie Macdonald, CEO, Parexel
              Andy Coravos, CEO, Elektra Labs
              Rob Scott, Chief Medical Officer, Abbvie
              Pavan Cheruvu, CEO, Axovant

    11:45 pm- 12:30 pm

    Innovation Showcase
              Kate Hermans, Chief Business Officer for Pharma, 83bar
              David Kiger, Chief Commercial Officer, Datacubed Health
              Michal Rys, Co-Founder & CEO, Dr0mnibus
              Meghan Conroy, CEO & Founder, CaptureProof
              Hosted by Daniel Chui, GSK & Georgia Mitsi, Sunovion

    12:30 pm- 1:00 pm

    Lunch (provided)

    1:00 pm- 3:00 pm

    CNS Summit Spotlight Sessions:

    Spotlight: Decentralized Trials: Where Does the Industry Stand?     1-2pm
              Leslie Shinobu, Portfolio Transformation Team, Biogen
              Susan Wong, Sr Director, Strategic & Clinical Operations, Transparency Life Sciences
              Vishall Mehra, CEO & Medical Director, Artemis Institute for Clinical Research
              Chair: Katherine Vandebelt, Global Head of Clinical Innovation, Oracle Health Sciences

    Spotlight: Decentralized Trials       2-3pm
              Michelle Longmire, CEO, Medable
              Josh Rose, Global Head Virtual Trial Operations, IQVIA
              John Reites, Chief Product Officer, THREAD
              Anthony Costello, SVP, Medidata
              Jonathan Cotliar, Chief Medical Officer, Science37
              Chair: Craig Lipset, Founder & Advisor, Clinical Innovation Partners

    Spotlight: Neuroscience       1-3pm
              Jonas Hannestad, VP Clinical Development, Alkahest
              Volker Knappertz, Chief Medical Officer, GW Pharmaceuticals
              Roger Crystal, CEO, Opiant
              Randall Owen, Chief Medical Officer, Navitor Pharma
              Chad Beyer, Senior Vice President, Research & Development, Promentis Pharmaceuticals
              Clare Stroud, Director, Neuroscience & Nervous System, NASEM
              Carla Canuso, Sr. Director, Clinical Development, J&J
              Co-Chair: Atul Mahableshwarkar, Sr Vice President, Research & Development, Emalex Biosciences
              Co-Chair: Roger Bullock, Chief Medical Officer, Oryzon Genomics

    Spotlight: Voice as an Endpoint in Clinical Trials       1-2pm
              Visar Berisha, Co-Founder, Chief Analytics Officer, Aural Analytics
              Zheng Yang, Head of Technology & Data Innovation, BI
              Michael Gold, VP, Development Neurosciences, AbbVie
              Pravin Jadhav, R&D Innovation, Otsuka
              Chair: Daniel Jones, CEO & Co-Founder, Aural Analytics

    Spotlight: Uncommon Solutions to Common Challenges in Rare Diseases   2-3pm
              Bola Oyegunwa, VP & Head of Virtual Trials, Covance
              Dekel Gelbman, CEO, FDNA
              Dina Katabi, Professor, MIT
              Chair: Cindy Jackson, VP & GM, Rare Diseases & Pediatrics, Covance

    Spotlight: DTx VR AR XR: Why Should Life Science Companies Care?       1-2pm
              Walter Greenleaf, Medical VR/AR Expert, Stanford University
              Brennan Spiegel, Director of Health Services Research, Cedars-Sinai
              Chair: Joe Powers, Chief Strategy Officer, AppliedVR

    Spotlight: Putting the Patient First with Predictive Analytics and Smarter eCOA       2-3pm
              Steve Brannan, Chief Medical Officer, Karuna Therapeutics
              Todd Solomon, Director Clinical Development, Avanir
              Dan DeBonis, Principal, Endpoint Solutions, Signant Health
              Gary Sachs, Clinical Vice President, Signant Health
              Chair: Mike Nolte, CEO, Signant Health

    Spotlight: The STARR Coalition: Ethics in Person-Centered CNS Research: Completing the Circle of Care       2-3pm
              Luke Kramer, Executive Director, The STARR Coalition
              Kim Vanover, SVP, Intra-Cellular Therapies
              Cecilia McGough, CEO, Students with Schizophrenia
              Corey Fowler, Associate Director, Global Clinical Development, Otsuka
              William Martin, Senior Director, Clinical Development, Alkermes
              Krista Armstrong, SVP, Head of Neuroscience, Premier Research
              Leslie Franceschi, Sr. Project Director, CNS Clinical Development, Syneos Health
             
    Innovation Showcase Updates       1-2pm
              Matthew Stoudt, CEO, AppliedVR
              Benjamin Vandendriessche, CMO, Byteflies
              Carrie Burke, VP, Business Development & Partnerships, Clinithink
              Francois Torche, CEO, Cluepoints
              Adam Hanina, CEO, AiCure
              Don Jones, Board Member, Seqster
              Chair: Spyros Papapetropoulos, Dept of Neurology, MGH

    3:30 pm- 5:00 pm

    One-to-One Networking Sessions

    5:00 pm- 7:00 pm

    Evening Reception, Posters & Exhibits
  • + -

    Sunday, November 3, 2019

    8:00 am- 8:45 am

    Breakfast

    9:00 am- 12:30 pm

    Pharma Innovation Summit

    Opening Session

    Sculley & Nosta: The Tech Talk
    John Sculley, Former CEO, Apple, Pepsi, Chairman, RxAdvance
    John Nosta, Founder, Nosta Lab, Google Advisory Board

    CNS Summit 2019 Innovation Index
    Amir Kalali, Chief Curator, CNS Summit
    Mike Rea, CEO, IDEA Pharma

    Pharma Innovation Panel
              Lisa von Moltke, SVP Head of Clinical Development, Alkermes
              Bruce Meadows, Head of Investments, Takeda Digital Ventures
              Rob Scott, Chief Medical Officer, AbbVie
              Ron Cohen, CEO, Acorda Therapeutics
              Co-Chair: Mike Rea, CEO, IDEA Pharma
              Co-Chair: GIl Bashe, Managing Partner, Global Health, Finn Partners

    Possibilities Panel
              Junaid Bajwa, Global Lead, Strategic Alliances, Digital Centre of Excellence, Merck
              Christian Jones, Chief Commercial Officer, Nanoform
              Shwen Gwee, Co- Founder & Global Head of Open Innovation, Novartis Biome


    Closing Ceremony

    12:30 pm

    Adjourn